Vestor Capital LLC cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 16,160 shares of the medical equipment provider’s stock after selling 140 shares during the period. Vestor Capital LLC’s holdings in Intuitive Surgical were worth $8,435,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also modified their holdings of the company. Atala Financial Inc acquired a new stake in Intuitive Surgical during the fourth quarter worth about $25,000. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical during the fourth quarter worth about $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth about $31,000. Finally, Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical during the fourth quarter worth about $36,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on ISRG shares. Bernstein Bank raised their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Barclays raised their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Citigroup raised their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Raymond James raised their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Finally, Piper Sandler restated an “overweight” rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $611.86.
Insiders Place Their Bets
In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is currently owned by insiders.
Intuitive Surgical Stock Performance
Intuitive Surgical stock opened at $492.49 on Friday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a 50 day moving average price of $562.24 and a two-hundred day moving average price of $531.34. The firm has a market cap of $175.41 billion, a price-to-earnings ratio of 76.83, a PEG ratio of 5.85 and a beta of 1.43.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- How to Profit From Value Investing
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Dividend Payout Ratio Calculator
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- What Investors Need to Know to Beat the Market
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.